Cover Image

In silico study unravels binding potential of madecassic acid against non-structural proteins of SARS-CoV-2

Backgrounds: COVID-19 is the ongoing global health emergency caused by SARS-CoV-2. Virions have multiple spike-glycoproteins on their surface to corrupt the host cells. Viral genome encodes for non-structural proteins 1-16 (NSP1-16) that orchestrate viral replication and immune evasion. Therefore, t...

Full description

Saved in:

Bibliographic Details
Main Authors:	Prem Rajak (Author), Abhratanu Ganguly (Author), Sukhendu Dey (Author), Anik Dutta (Author), Moutushi Mandi (Author)
Format:	Book
Published:	Elsevier, 2023-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Madecassic Acid Ameliorates the Progression of Osteoarthritis: An in vitro and in vivo Study
by: Fu X, et al.
Published: (2022)

Unravelling the Interaction of Piperlongumine with the Nucleotide-Binding Domain of HSP70: A Spectroscopic and In Silico Study
by: Ana Paula Ribeiro Povinelli, et al.
Published: (2021)

Inhibition Ability of Natural Compounds on Receptor-Binding Domain of SARS-CoV2: An In Silico Approach
by: Miroslava Nedyalkova, et al.
Published: (2021)

Pregnancy and SARS - CoV - 2 vaccination: Unraveling the myths
by: Anita Yadav, et al.
Published: (2021)

Ligand-Based and Structured-Based In Silico Repurposing Approaches to Predict Inhibitors of SARS-CoV-2 Mpro Protein
by: Alfredo Juárez-Saldívar, et al.
Published: (2020)

Effects of theaflavin-gallate in-silico binding with different proteins of SARS-CoV-2 and host inflammation and vasoregulations referring an experimental rat-lung injury
by: Smarajit Maiti, et al.
Published: (2022)

In Silico Comparison of Separate or Combinatorial Effects of Po-tential Inhibitors of the SARS-CoV-2 Binding Site of ACE2
by: Mostafa Shakhsi-Niaei, et al.
Published: (2021)

Comment on "In Silico Comparison of Separate or Combinatorial Effects of Potential Inhibitors of the SARS-CoV-2 Binding Site of ACE2"
by: Reza Gharebaghi, et al.
Published: (2022)

Unraveling Hepcidin Plasma Protein Binding: Evidence from Peritoneal Equilibration Testing
by: Laura E. Diepeveen, et al.
Published: (2019)

Response Comment on "In Silico Comparison of Separate or Combinatorial Effects of Potential Inhibitors of the SARS-CoV-2 Binding Site of ACE2"
by: Mostafa Shakhsi-Niaei, et al.
Published: (2022)

Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites
by: Sisi Kang, et al.
Published: (2020)

Lactoferrin Binds through Its N-Terminus to the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
by: Patrik Babulic, et al.
Published: (2024)

Is the shielding effect of cholecalciferol in SARS CoV-2 infection dependable? An evidence based unraveling
by: Shaik Lahoor Basha, PharmD, et al.
Published: (2021)

Structure-based design of oligomeric receptor-binding domain (RBD) recombinant proteins as potent vaccine candidates against SARS-CoV-2
by: Ting Zhang, et al.
Published: (2023)

Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies
by: Romain Rouet, et al.
Published: (2021)

In silico phytochemicals analysis as inhibitors of the SARS-COV-2 main protease
by: Ekaterina Serikova, et al.
Published: (2022)

Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences
by: Elena Campione, et al.
Published: (2021)

Novel Small-Molecule Inhibitors of the SARS-CoV-2 Spike Protein Binding to Neuropilin 1
by: Anja Kolarič, et al.
Published: (2022)

Conventional Teaching in Basic Science: An inner view
by: Sukhendu Dutta
Published: (2010)

Incidence and distribution of anomalous coronary artery: analysis of 94 necropsy cases
by: Sukhendu Dutta
Published: (2014)

A horizon of medical education research approach in 21st century
by: Sukhendu Dutta
Published: (2014)

Comparative In-Silico Molecular Docking of Silymarin for SARS-CoV-2 Receptor
by: Michael Antony Samy Amutha Gnana Arasi, et al.
Published: (2022)

Assessment of the binding interactions of SARS-CoV-2 spike glycoprotein variants
by: Deepa Raghu, et al.
Published: (2022)

In-silico study MM/GBSA binding free energy and molecular dynamics simulation of some designed remdesivir derivatives as the inhibitory potential of SARS-CoV-2 main protease
by: Maryam Abbasi, et al.
Published: (2024)

In Silico Prediction of Novel Inhibitors of SARS-CoV-2 Main Protease through Structure-Based Virtual Screening and Molecular Dynamic Simulation
by: Sobia Ahsan Halim, et al.
Published: (2021)

Spike protein of SARS-CoV-2 Omicron variant: An in-silico study evaluating spike interactions and immune evasion
by: Jose A. Jimenez Ruiz, et al.
Published: (2022)

Kaempferia parviflora Wall. ex Baker against SARS-CoV-2 spike protein: In silico and in vitro studies
by: Suhaina Supian, et al.
Published: (2024)

In Silico Study for Similar FDA Approved Drugs as Inhibitors of SARS-CoV-2 Spike and the Host Receptor Proteins
by: Israa Mohamed Shamkh, et al.
Published: (2021)

Glyceraldehyde-3-Phosphate Dehydrogenase Binds with Spike Protein and Inhibits the Entry of SARS-CoV-2 into Host Cells
by: Rahul Dilawari, et al.
Published: (2024)

An in Silico Approach to Find the Molecular Targets and Potential Candidates for SARS-CoV-2
by: Amir Zarrinhaghighi, et al.
Published: (2020)

Plant Metabolites as SARS-CoV-2 Inhibitors Candidates: In Silico and In Vitro Studies
by: Alberto Jorge Oliveira Lopes, et al.
Published: (2022)

Binding and neutralizing abilities of antibodies towards SARS-CoV-2 S2 domain
by: Xingsu Gao, et al.
Published: (2022)

Neutralizing antibody response elicited by SARS-CoV-2 receptor-binding domain
by: Ping-Han Huang, et al.
Published: (2021)

Unravelling the allosteric binding mode of αD-VxXXB at nicotinic acetylcholine receptors
by: Thao NT Ho, et al.
Published: (2023)

Conservation and Enhanced Binding of SARS-CoV-2 Omicron Spike Protein to Coreceptor Neuropilin-1 Predicted by Docking Analysis
by: Piyush Baindara, et al.
Published: (2022)

Discovery of DNA aptamers targeting SARS-CoV-2 nucleocapsid protein and protein-binding epitopes for label-free COVID-19 diagnostics
by: Suttinee Poolsup, et al.
Published: (2023)

Iterative In Silico Screening for Optimizing Stable Conformation of Anti-SARS-CoV-2 Nanobodies
by: Wenyuan Shang, et al.
Published: (2024)

In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2
by: Sathish Kumar Chidambaram, et al.
Published: (2020)

In Silico Drug Repurposing of Penicillins to Target Main Protease Mpro of SARS-CoV-2
by: Baby Krishnaprasad, et al.
Published: (2020)

Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines
by: Xiaoqing Guan, et al.
Published: (2023)